1. MARKETS
  2. SECTOR : COMMERCIAL SERVICES & SUPPLIES
  3. INDUSTRY : MISCELLANEOUS COMMERCIAL SERVICES
  4. MURAL ONCOLOGY PLC

Mural Oncology plc

XNAS: MURA

Download real time

4.05 -0.02 (-0.49%)

41.11% Gain from 52W Low

42,791 XNAS Volume

XNAS 18 Mar, 2025 1:18 PM (EDT)

Watchlist

Portfolio

Share
14S
7W
0O
2T
69.8

Market Cap

Below industry Median
-0.5

PE TTM

Negative PE TTM
0

PEG TTM

0.4

Price to Book

Low in industry
0.2

Beta 1Year

Very Low volatility
Board Meeting
The next board meeting for Mural Oncology plc is on 26 Mar 2025 for the purpose of Mural Oncology PLC Fourth Quarter Earnings Results for 2024 See details


Insider Trading disclosures for Mural Oncology plc

The latest disclosure was made by Caroline Loew in Mural Oncology plc where a trade of 134,225 Stock Option (right to buy) done was reported to US exchanges on March 3, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Caroline Loew Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2025 134,225 134,225 - - Stock Option (right to buy)
Maiken Keson-Brookes See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2025 35,000 76,295 - 0 Ordinary Shares
Maiken Keson-Brookes See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2025 65,000 65,000 - - Stock Option (right to buy)
Maiken Keson-Brookes See Remarks Sale of securities on an exchange or to another person at price $ 3.45 per share. 03 Mar 2025 1,469 73,564 - 3.4 5,068 Ordinary Shares
Maiken Keson-Brookes See Remarks Sale of securities on an exchange or to another person at price $ 3.36 per share. 03 Mar 2025 1,262 75,033 - 3.4 4,240 Ordinary Shares
Adam D. Cutler Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2025 35,000 106,438 - 0 Ordinary Shares
Adam D. Cutler Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2025 65,000 65,000 - - Stock Option (right to buy)
Vicki L. Goodman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2025 65,000 65,000 - - Stock Option (right to buy)
Vicki L. Goodman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2025 35,000 89,763 - 0 Ordinary Shares
Caroline Loew Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 3.36 per share. 03 Mar 2025 4,313 305,590 - 3.4 14,492 Ordinary Shares
Caroline Loew Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2025 72,275 309,903 - 0 Ordinary Shares
Vicki L. Goodman Chief Medical Officer Sale of securities on an exchange or to another person at price $ 3.89 per share. 24 Feb 2025 13,186 54,763 - 3.9 51,294 Ordinary Shares
Keson-Brookes Maiken See Remarks Sale of securities on an exchange or to another person at price $ 3.27 per share. 23 Dec 2024 2,555 41,295 - 3.3 8,355 Ordinary Shares
Loew Caroline Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 3.40 per share. 17 Dec 2024 2,763 237,628 - 3.4 9,394 Ordinary Shares
Vicki L. Goodman Chief Medical Officer Sale of securities on an exchange or to another person at price $ 3.33 per share. 07 Nov 2024 5,069 67,949 - 3.3 16,880 Ordinary Shares
Adam D. Cutler Chief Financial Officer Sale of securities on an exchange or to another person at price $ 3.41 per share. 31 Oct 2024 7,421 71,438 - 3.4 25,306 Ordinary Shares
Sachiyo Minegishi Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Sep 2024 15,335 15,335 - - Stock Option (right to buy)
Susan Altschuller Director Purchase of securities on an exchange or from another person at price $ 3.21 per share. 14 Aug 2024 10,000 10,000 - 3.2 32,071 Ordinary Shares
George S. Golumbeski Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Jul 2024 15,334 15,334 - - Stock Option (right to buy)
Maiken Keson-Brookes See Remarks Sale of securities on an exchange or to another person at price $ 3.41 per share. 18 Jul 2024 2,157 43,850 - 3.4 7,355 Ordinary Shares
Caroline Loew Director, Chief Executive Officer Sale of securities on an exchange or to another person at price $ 2.91 per share. 08 Jul 2024 12,531 240,391 - 2.9 36,465 Ordinary Shares
Susan Altschuller Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 May 2024 8,462 8,462 - - Stock Option (right to buy)
Benjamin J. Hickey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 May 2024 8,462 8,462 - - Stock Option (right to buy)
Francis M. Cuss Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 May 2024 8,462 8,462 - - Stock Option (right to buy)
Scott T. Jackson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 May 2024 8,462 8,462 - - Stock Option (right to buy)
Susan Altschuller Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 May 2024 8,462 8,462 - - Stock Option (right to buy)
Benjamin J. Hickey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 May 2024 8,462 8,462 - - Stock Option (right to buy)
Francis M. Cuss Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 May 2024 8,462 8,462 - - Stock Option (right to buy)
Scott T. Jackson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 May 2024 8,462 8,462 - - Stock Option (right to buy)
Maiken Keson-Brookes See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 31,200 31,200 - - Stock Option (right to buy)
Maiken Keson-Brookes See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 16,800 46,007 - 0 Ordinary Shares
Caroline Loew Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 48,475 252,922 - 0 Ordinary Shares
Caroline Loew Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2024 90,025 90,025 - - Stock Option (right to buy)
Susan Altschuller Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2023 15,021 15,021 - - Stock Option (right to buy)
Benjamin J. Hickey Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2023 15,021 15,021 - - Stock Option (right to buy)
Adam D. Cutler Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2023 78,859 78,859 - 0 Ordinary Shares
Adam D. Cutler Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2023 146,452 146,452 - - Stock Option (right to buy)
Maiken Keson-Brookes See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2023 29,207 29,207 - 0 Ordinary Shares
Maiken Keson-Brookes See Remarks Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2023 54,242 54,242 - - Stock Option (right to buy)
Francis M. Cuss Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2023 15,021 15,021 - - Stock Option (right to buy)
Scott T. Jackson Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2023 15,021 15,021 - - Stock Option (right to buy)
Vicki L. Goodman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2023 73,018 73,018 - 0 Ordinary Shares
Vicki L. Goodman Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2023 135,604 135,604 - - Stock Option (right to buy)
Caroline Loew Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Dec 2023 379,690 379,690 - - Stock Option (right to buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters